Claritin and Multaq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Claritin (loratadine) and Multaq (dronedarone hydrochloride). Common drug interactions include contusion among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Claritin and Multaq. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,316 Claritin users. Check the latest studies of Claritin.

What is Multaq?

Multaq has active ingredients of dronedarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 11,053 Multaq users. Check the latest studies of Multaq.

On Aug, 07, 2026

69 people who take Claritin and Multaq together, and have interactions are studied.

What are the common drug interactions of Claritin and Multaq, by gender? *:

female:

Contusion (a type of hematoma of tissue in which capillaries)
Cough
Depression
Diverticular perforation (serious gastrointestinal condition in which the intestine's walls are perforated)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Dizziness
Embolism arterial (blood clot that has travelled through your arteries and become stuck)
Epistaxis (bleed from the nose)
Eructation (release of gas from the digestive tract)
Fatigue (feeling of tiredness)

male:

Dyspnoea (difficult or laboured respiration)
Acute respiratory failure
Pneumonia
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Cardiac arrest
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)

What are the common drug interactions of Claritin and Multaq, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Embolism arterial (blood clot that has travelled through your arteries and become stuck)

40-49:

Labyrinthitis (inflammation of the labyrinth or inner ear)
Multiple injuries
Oedema peripheral (superficial swelling)
Pain
Palpitations (feelings or sensations that your heart is pounding or racing)
Pneumonia
Quality of life decreased
Sinusitis (inflammation of sinus)
Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle)
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)

50-59:

Micturition urgency (urgency to pass the urine)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Blood cholesterol increased
Dizziness
Haemoglobin decreased
Hypoaesthesia (reduced sense of touch or sensation)
Weight increased

60+:

Dyspnoea (difficult or laboured respiration)
Oedema peripheral (superficial swelling)
Death
Diarrhoea
Muscle spasms (muscle contraction)
Urinary tract infection
Influenza like illness
Pruritus (severe itching of the skin)
Cardiac disorder
Cerebral haemorrhage (bleeding within the brain)

What are the existing conditions these people have? *

Pain: 14 people, 20.29%
High Blood Pressure: 13 people, 18.84%
Hypersensitivity: 7 people, 10.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 10.14%
Cardiac Disorder: 7 people, 10.14%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 7.25%
Multiple Myeloma (cancer of the plasma cells): 5 people, 7.25%
High Blood Cholesterol: 5 people, 7.25%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 7.25%
Asthma: 5 people, 7.25%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and Multaq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously